, Tracking Stock Market Picks
Enter Symbol:

up 521.67 %

MEDIVATION INC (MDVN) rated Outperform with price target $39 by Leerink Swann

Posted on: Tuesday,  Mar 17, 2009  8:25 AM ET by Leerink Swann

Leerink Swann rated Outperform MEDIVATION INC (NASDAQ: MDVN) on 03/17/2009. Previously Leerink Swann rated Outperform MEDIVATION INC (NASDAQ: MDVN) on
09/04/2008., when the stock price was $14.81. Since then, MEDIVATION INC has gained 521.67% as of 01/27/2016's recent price of $92.07.
If you would have followed the previous Leerink Swann 's recommendation on MDVN, you would have gained 521.67% of your investment in 2701 days.

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease, Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/17/2009 8:25 AM Buy
8.20 19.50
as of 12/31/2009
1 Week down  -62.89 %
1 Month down  -52.93 %
3 Months down  -46.75 %
1 YTD down  -0.82 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/4/2008 8:25 AM Buy
14.81 25.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy